This week in drug discovery 8-12 September
News round-up for 8-12 September by DDW Editor Reece Armstrong.
Fast-track designations by the FDA, clinical trials to advance mental health and pharma team-ups to bring innovations to market are just some of the stories in this week’s news round-up.
The top stories
FDA fast-tracks Sanofi’s AMD gene therapy
Sanofi’s investigational one-time intravitreal gene therapy for the treatment of neovascular age-related macular degeneration (AMD) has been granted fast track designation by the US Food and Drug Administration (FDA).
First NHS-embedded clinical trial site for mental health launches
The UK’s first fully NHS-embedded commercial research for brain and mental health conditions has been launched by Clerkenwell Health.
Pioneer and AbbVie team up on a Golden Ticket to accelerate human health
Pioneer Group, a specialist in life science infrastructure and venture building, has again teamed up with biopharmaceutical company AbbVie to launch a Golden Ticket programme designed to accelerate companies developing novel, transformational therapies and innovations for immunology, oncology, neurology, eye care, aesthetics, or other specialities including obesity, GI and hepatology.
MoU signed to advance precision medicine growth in Serbia
MultiOmic Health (MOH), an artificial intelligence (AI)-enabled precision medicine biotechnology company, and BIO4 Campus (BIO4), the Republic of Serbia’s flagship biotechnology and life sciences hub, have announced the signing of a Memorandum of Understanding (MoU) to explore collaborative opportunities in biomedicine, biotechnology and bioinformatics, with a strong emphasis on AI applications.
New NICE thresholds is good news for ultra-rare disease drugs, says biotech
The National Institute for Health and Care Excellence (NICE), the body that determines the clinical effectiveness and economic value of new medicines, has increased the cost-effectiveness thresholds it applies for drugs that qualify for their Highly Specialised Technology (HST) programme.
